Cargando…

Hepatic interleukin‐1 receptor type 1 signalling regulates insulin sensitivity in the early phases of nonalcoholic fatty liver disease

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is associated with hepatic as well as systemic insulin resistance even in the absence of type 2 diabetes. The extent and pathways through which hepatic inflammation modulates insulin sensitivity in NAFLD are only partially understood. We explored...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gehrke, Nadine, Hofmann, Lea J., Straub, Beate K., Rühle, Frank, Waisman, Ari, Galle, Peter R., Schattenberg, Jörn M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471277/ https://www.ncbi.nlm.nih.gov/pubmed/36101976 http://dx.doi.org/10.1002/ctm2.1048

Ejemplares similares

Hepatocyte Bcl-3 protects from death-receptor mediated apoptosis and subsequent acute liver failure
por: Gehrke, Nadine, et al.
Publicado: (2022)

Cardiovascular Risk Categories in Patients With Nonalcoholic Fatty Liver Disease and the Role of Low‐Density Lipoprotein Cholesterol
por: Labenz, Christian, et al.
Publicado: (2019)

Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters – an animal model of life style intervention in NAFLD
por: Gehrke, Nadine, et al.
Publicado: (2019)

Hepatic B cell leukemia-3 suppresses chemically-induced hepatocarcinogenesis in mice through altered MAPK and NF-κB activation
por: Gehrke, Nadine, et al.
Publicado: (2016)

Incident Dementia in Elderly Patients with Nonalcoholic Fatty Liver Disease in Germany
por: Labenz, Christian, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and Depression
por: Labenz, Christian, et al.
Publicado: (2020)

Characteristics of hepatic insulin‐sensitive nonalcoholic fatty liver disease
por: Shigiyama, Fumika, et al.
Publicado: (2017)

Hepatic iron concentration correlates with insulin sensitivity in nonalcoholic fatty liver disease
por: Britton, Laurence, et al.
Publicado: (2018)

Interleukin‐32 Contributes to Human Nonalcoholic Fatty Liver Disease and Insulin Resistance
por: Dali‐Youcef, Nassim, et al.
Publicado: (2019)

Voluntary distance running prevents TNF-mediated liver injury in mice through alterations of the intrahepatic immune milieu
por: Huber, Yvonne, et al.
Publicado: (2017)

Web-Based Exercise as an Effective Complementary Treatment for Patients With Nonalcoholic Fatty Liver Disease: Intervention Study
por: Pfirrmann, Daniel, et al.
Publicado: (2019)

Prevalence and risk factors of nonalcoholic steatohepatitis with significant fibrosis in people with HIV
por: Michel, Maurice, et al.
Publicado: (2022)

Impact of thyroid disorders on the incidence of non‐alcoholic fatty liver disease in Germany
por: Labenz, Christian, et al.
Publicado: (2021)

Transforming Growth Factor-β Activated Kinase 1 (Tak1) Is Activated in Hepatocellular Carcinoma, Mediates Tumor Progression, and Predicts Unfavorable Outcome
por: Ridder, Dirk Andreas, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease and insulin resistance in children
por: Song, Kyungchul, et al.
Publicado: (2023)

Loss of organic cation transporter 3 (Oct3) leads to enhanced proliferation and hepatocarcinogenesis
por: Vollmar, Johanna, et al.
Publicado: (2017)

Hepatic Notch Signaling Correlates With Insulin Resistance and Nonalcoholic Fatty Liver Disease
por: Valenti, Luca, et al.
Publicado: (2013)

Role of Chitinase 3-Like 1 Protein in the Pathogenesis of Hepatic Insulin Resistance in Nonalcoholic Fatty Liver Disease
por: Zhang, Songhua, et al.
Publicado: (2021)

Serum Interleukin‐8, Osteopontin, and Monocyte Chemoattractant Protein 1 Are Associated With Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
por: Glass, Oliver, et al.
Publicado: (2018)

Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver
por: Dongiovanni, P., et al.
Publicado: (2017)

Hypoadiponectinemia and Insulin Resistance are Associated with Nonalcoholic Fatty Liver Disease
por: Yoon, Dokyoung, et al.
Publicado: (2005)

Mechanisms of Insulin Resistance in Primary and Secondary Nonalcoholic Fatty Liver
por: Jelenik, Tomas, et al.
Publicado: (2017)

The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease
por: Fujii, Hideki, et al.
Publicado: (2020)

Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease
por: Armandi, Angelo, et al.
Publicado: (2021)

Overexpression of Interleukin-8 Promotes the Progression of Fatty Liver to Nonalcoholic Steatohepatitis in Mice
por: Cho, Ye Eun, et al.
Publicado: (2023)

Metabolic dysfunction-associated fatty liver disease in people living with HIV
por: Michel, Maurice, et al.
Publicado: (2023)

Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease
por: Sen, Partho, et al.
Publicado: (2022)

Circulating Level of CTRP1 in Patients with Nonalcoholic Fatty Liver Disease (NAFLD): Is It through Insulin Resistance?
por: Shabani, Parisa, et al.
Publicado: (2015)

Noninvasive Testing Using Magnetic Resonance Imaging Techniques as Outcomes in Nonalcoholic Steatohepatitis Clinical Trials: How Full Is the Glass?
por: Noureddin, Nabil, et al.
Publicado: (2020)

Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Schattenberg, Jörn M., et al.
Publicado: (2019)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Cha, Ji-Young, et al.
Publicado: (2018)

Nutritional Management of Insulin Resistance in Nonalcoholic Fatty Liver Disease (NAFLD)
por: Conlon, Beth A., et al.
Publicado: (2013)

Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease
por: Akhtar, Daud H., et al.
Publicado: (2019)

Nonalcoholic fatty liver disease and the risk of insulin-requiring gestational diabetes
por: You, Sang Youn, et al.
Publicado: (2021)

Hepatic Innervations and Nonalcoholic Fatty Liver Disease
por: Adori, Monika, et al.
Publicado: (2023)

Elevated levels of Bcl-3 inhibits Treg development and function resulting in spontaneous colitis
por: Reißig, Sonja, et al.
Publicado: (2017)

Tyrosine levels are associated with insulin resistance in patients with nonalcoholic fatty liver disease
por: Kawanaka, Miwa, et al.
Publicado: (2015)

Nonalcoholic Fatty Liver Disease and Thrombocytopenia III: Its Association With Insulin Resistance
por: López-Trujillo, Miguel Antonio, et al.
Publicado: (2019)

Assessing the disease burden of non-alcoholic fatty liver disease in the real world – big data and big numbers
por: Schattenberg, Jörn M., et al.
Publicado: (2019)

Beyond the Paradigm of Weight Loss in Non-Alcoholic Fatty Liver Disease: From Pathophysiology to Novel Dietary Approaches
por: Armandi, Angelo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gf4v6a40qr4r2741vups374f2j